POSTER ABSTRACTS / RESUMOS DE POSTERS

 

P-21

Intronic long interspersed nuclear element (LINE-1) insertion in the DMD gene as a cause of Becker muscular dystrophy

 

 

Ana Gonçalves^I,V; Teresa Coelho^II; Jorge Oliveira^I,V; Emília Vieira^I,V; Ricardo Taipa^III; Manuel Melo Pires^III; Elsa Bronze da Rocha^IV; Rosário Santos^I,IV,V

^I Unidade de Genética Molecular, Centro Genética Médica Doutor Jacinto Magalhães - Centro Hospitalar do Porto, EPE - Porto, Portugal
^II Consulta de Neurologia/Doenças Neuromusculares, Centro Hospitalar do Porto - EPE, Porto, Portugal
^III Unidade de Neuropatologia, Centro Hospitalar do Porto - EPE, Porto, Portugal
^IV UCIBIO/REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
^V Unidade Multidisciplinar de Investigação Biomédica (UMIB), Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto,Porto, Portugal

ana.goncalves@chporto.min-saude.pt

 

 

Long interspersed nuclear elements (LINE-1 or L1) are the most abundant retrotransposable elements accounting for nearly 17% of the human  genome.  These elements can be randomly incorporated in the genome, therefore having an important role in its plasticity and in generating structural genetic variants. It has been demonstrated that L1 retrotransposon activity may occasionally cause genetic diseases. To date, only four disease-causing L1 elements have been described in the dystrophin (DMD) gene; three inserted in exons 44, 48 and 67, in patients with a Duchenne muscular dystrophy (DMD)  phenotype,  and  one  detected in the 5´untranslated region, in two apparently unrelated Japanese families with X-linked dilated cardiomyopathy.

We report a 48 year old man with a clinical diagnosis of  Becker  muscular  dystrophy  (BMD),  in  2001,  without molecular confirmation by multiplex PCR and Southern-Blot analysis, and whose diagnosis was recently revisited because his daughter is considering pregnancy. A second molecular study,  resorting  to  multiplex  ligation-probe  amplification (MLPA) analysis and genomic DMD gene sequencing, again failed to detect abnormalities. A new muscle biopsy showed dystrophic features with irregular labeling for dystrophin on immunohistochemical analysis, suggesting dystrophinopathy. With  the  intention  of  unveiling  a  genetic  defect  that might be refractory to the previous diagnostic techniques, muscle-derived  DMD  transcripts  were  sequenced  in  their entirety.  Results  revealed  an  insertion  of  103  nucleotides between exons 51 and 52, which showed no homology to the gene’s reference sequence. Extensive bioinformatic analysis (homology search and splice-site/branch-point analysis) and sequential direct sequencing enabled the discovery of a deep intronic insertion of an L1 element, in intron 51. This extremely rare mutational event resulted in the partial exonization of the L1 plus 5 nucleotides of intron 51. In addition to the aberrant out-of-frame transcript, a residually expressed wild-type transcript was also detected, thereby explaining the milder phenotype in this patient.

To our knowledge this is the first report ever of dystrophinopathy caused by an intronically placed L1 element. Besides representing an exceptional contribution towards widening the DMD gene mutation spectrum, this study highlights the importance of conducting mRNA studies in as yet uncharacterized BMD/DMD patients. This holds true even considering some of the most recent state-of-the-art screening approaches, based on next-generation sequencing technology, where this type of mutation may ultimately fail to be detected.